ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹221 Cr | ₹8352 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 3.64% | 2.67% |
6 Month | -6.54% | -2.54% |
1 Year | 15.59% | 15.72% |
3 Year | 23.7% | 25.23% |
5 Year | - | 22.27% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 5.42% | 7.99% |
1 Year | 3.19% | 9.25% |
3 Year | 22.52% | 24.61% |
5 Year | - | 20.08% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 20.48% | 17.67% |
3 Year | 18.71% | 20.32% |
5 Year | - | 20.52% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.61% | 14.96% |
Sharp | 0.93% | 1.07% |
Beta | 0.94% | 0.90% |
Alpha | -0.87% | 1.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.38 | 1.42 |
Mid Cap | 34.93 | 31.26 |
Small Cap | 33.22 | 30.78 |
Large Cap | 30.47 | 36.54 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 0.29 | 1.42 |
Healthcare | 95.15 | 98.58 |
Basic Materials | 3.63 | - |
Industrials | 0.93 | - |
Top Comparisons
360 ONE FlexiCap Fund Regular - Growth
3Y Returns0%
Quant Flexi Cap Fund-Growth
3Y Returns23.98%
SBI Magnum Low Duration Fund - Regular Plan - Growth
3Y Returns7.02%
Tata Treasury Advantage Fund - Regular Plan - Growth Option
3Y Returns7.09%
ICICI Prudential Large Cap Fund - Growth
3Y Returns22.64%
BANDHAN Large Cap Fund - Regular Plan - Growth
3Y Returns20.55%
Kotak Medium Term Fund - Growth
3Y Returns7.82%
DSP Bond Fund - Growth
3Y Returns7.87%